These results suggest that elafin-positive cells, even at low frequency, were independently prognostic of reduced RFS in breast cancer patients, particularly with IHC-defined luminal A-like (ER+/PR+/Ki67low) subtype tumors. The gene discussed is PGR; the disease is breast carcinoma.